Natural killer cells could redefine medicine and offer new hope for cancer, autoimmune diseases, and neurological disorders through advanced CAR-NK therapies.
Alan Trounson, PhD, MSc
Advertisement
CEO and executive director, Cartherics Pty Ltd; Emeritus professor, Monash University; Distinguished Scientist, Hudson Institute of Medical Research
Articles by Alan Trounson, PhD, MSc
The chief executive officer of Cartherics discussed the company’s development of NK cell, T-cell, and macrophage cell therapies for various solid tumor indications.
Advertisement
Latest Updated Articles
The Power and Potential of Natural Killer Cell Therapies: A New AwakeningPublished: December 19th 2024 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
3
Guess the Therapy Answer October 16, 2025
4
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
5
